Literature DB >> 27836900

Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.

Parker S Woods1, Lauren M Doolittle1, Lucia E Rosas1, Lisa M Joseph1, Edward P Calomeni2, Ian C Davis3.   

Abstract

Alveolar type II (ATII) epithelial cells are the primary site of influenza virus replication in the distal lung. Development of acute respiratory distress syndrome in influenza-infected mice correlates with significant alterations in ATII cell function. However, the impact of infection on ATII cell surfactant lipid metabolism has not been explored. C57BL/6 mice were inoculated intranasally with influenza A/WSN/33 (H1N1) virus (10,000 plaque-forming units/mouse) or mock-infected with virus diluent. ATII cells were isolated by a standard lung digestion protocol at 2 and 6 days postinfection. Levels of 77 surfactant lipid-related compounds of known identity in each ATII cell sample were measured by ultra-high-performance liquid chromatography-mass spectrometry. In other mice, bronchoalveolar lavage fluid was collected to measure lipid and protein content using commercial assay kits. Relative to mock-infected animals, ATII cells from influenza-infected mice contained reduced levels of major surfactant phospholipids (phosphatidylcholine, phosphatidylglycerol, and phosphatidylethanolamine) but increased levels of minor phospholipids (phosphatidylserine, phosphatidylinositol, and sphingomyelin), cholesterol, and diacylglycerol. These changes were accompanied by reductions in cytidine 5'-diphosphocholine and 5'-diphosphoethanolamine (liponucleotide precursors for ATII cell phosphatidylcholine and phosphatidylethanolamine synthesis, respectively). ATII cell lamellar bodies were ultrastructurally abnormal after infection. Changes in ATII cell phospholipids were reflected in the composition of bronchoalveolar lavage fluid, which contained reduced amounts of phosphatidylcholine and phosphatidylglycerol but increased amounts of sphingomyelin, cholesterol, and protein. Influenza infection significantly alters ATII cell surfactant lipid metabolism, which may contribute to surfactant dysfunction and development of acute respiratory distress syndrome in influenza-infected mice.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  acute respiratory distress syndrome; alveolar type II cell; influenza; lipidomics; liponucleotide; mouse; phospholipid; surfactant

Mesh:

Substances:

Year:  2016        PMID: 27836900      PMCID: PMC5206402          DOI: 10.1152/ajplung.00339.2016

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   6.011


  56 in total

1.  The first case of H5N1 avian influenza infection in a human with complications of adult respiratory distress syndrome and Reye's syndrome.

Authors:  A S Ku; L T Chan
Journal:  J Paediatr Child Health       Date:  1999-04       Impact factor: 1.954

Review 2.  Diseases of pulmonary surfactant homeostasis.

Authors:  Jeffrey A Whitsett; Susan E Wert; Timothy E Weaver
Journal:  Annu Rev Pathol       Date:  2015       Impact factor: 23.472

3.  Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.

Authors:  R Schmidt; U Meier; M Yabut-Perez; D Walmrath; F Grimminger; W Seeger; A Günther
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

Review 4.  Surfactant phospholipid metabolism.

Authors:  Marianna Agassandian; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2012-09-29

5.  Obesity Increases Mortality and Modulates the Lung Metabolome during Pandemic H1N1 Influenza Virus Infection in Mice.

Authors:  J Justin Milner; Jenny Rebeles; Suraj Dhungana; Delisha A Stewart; Susan C J Sumner; Matthew H Meyers; Peter Mancuso; Melinda A Beck
Journal:  J Immunol       Date:  2015-04-10       Impact factor: 5.422

6.  Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice.

Authors:  Famke Aeffner; Anna Bratasz; Emilio Flaño; Kimerly A Powell; Ian C Davis
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-07       Impact factor: 6.914

7.  Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells.

Authors:  Aida Ibricevic; Andrew Pekosz; Michael J Walter; Celeste Newby; John T Battaile; Earl G Brown; Michael J Holtzman; Steven L Brody
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

8.  Influenza and the winter increase in mortality in the United States, 1959-1999.

Authors:  Thomas A Reichert; Lone Simonsen; Ashutosh Sharma; Scott A Pardo; David S Fedson; Mark A Miller
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

Review 9.  Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells.

Authors:  Jean E Vance; Guergana Tasseva
Journal:  Biochim Biophys Acta       Date:  2012-08-29

10.  Outcome of critically ill patients with influenza virus infection.

Authors:  Guangxi Li; Murat Yilmaz; Marija Kojicic; Evans Fernández-Pérez; Raed Wahab; W Charles Huskins; Bekele Afessa; Jonathon D Truwit; Ognjen Gajic
Journal:  J Clin Virol       Date:  2009-08-20       Impact factor: 3.168

View more
  24 in total

1.  Host lipidome analysis during rhinovirus replication in HBECs identifies potential therapeutic targets.

Authors:  An Nguyen; Anabel Guedán; Aurelie Mousnier; Dawid Swieboda; Qifeng Zhang; Dorottya Horkai; Nicolas Le Novere; Roberto Solari; Michael J O Wakelam
Journal:  J Lipid Res       Date:  2018-06-26       Impact factor: 5.922

2.  IFITM3 protects the heart during influenza virus infection.

Authors:  Adam D Kenney; Temet M McMichael; Alexander Imas; Nicholas M Chesarino; Lizhi Zhang; Lisa E Dorn; Qian Wu; Omar Alfaour; Foued Amari; Min Chen; Ashley Zani; Mahesh Chemudupati; Federica Accornero; Vincenzo Coppola; Murugesan V S Rajaram; Jacob S Yount
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

Review 3.  Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques.

Authors:  Chrysi Keskinidou; Alice G Vassiliou; Ioanna Dimopoulou; Anastasia Kotanidou; Stylianos E Orfanos
Journal:  J Inflamm Res       Date:  2022-06-15

Review 4.  Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components.

Authors:  Dan Li; Xianzheng Wang; Yingzhao Liao; Shouchuan Wang; Jinjun Shan; Jianjian Ji
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

5.  Cytidine 5'-Diphosphocholine Corrects Alveolar Type II Cell Mitochondrial Dysfunction in Influenza-infected Mice.

Authors:  Lauren M Doolittle; Katherine Binzel; Katherine E Nolan; Kelsey Craig; Lucia E Rosas; Matthew C Bernier; Lisa M Joseph; Parker S Woods; Michael V Knopp; Ian C Davis
Journal:  Am J Respir Cell Mol Biol       Date:  2022-06       Impact factor: 7.748

6.  Postexposure Liponucleotide Prophylaxis and Treatment Attenuates Acute Respiratory Distress Syndrome in Influenza-infected Mice.

Authors:  Lucia E Rosas; Lauren M Doolittle; Lisa M Joseph; Hasan El-Musa; Michael V Novotny; Judy M Hickman-Davis; R Duncan Hite; Ian C Davis
Journal:  Am J Respir Cell Mol Biol       Date:  2021-06       Impact factor: 6.914

7.  Metabolic shifts modulate lung injury caused by infection with H1N1 influenza A virus.

Authors:  Katherine E Nolan; Lisa A Baer; Priyanka Karekar; Andrew M Nelson; Kristin I Stanford; Lauren M Doolittle; Lucia E Rosas; Judy M Hickman-Davis; Harpreet Singh; Ian C Davis
Journal:  Virology       Date:  2021-04-06       Impact factor: 3.513

8.  Increased expression of microRNA-155-5p by alveolar type II cells contributes to development of lethal ARDS in H1N1 influenza A virus-infected mice.

Authors:  Parker S Woods; Lauren M Doolittle; Lucia E Rosas; S Patrick Nana-Sinkam; Esmerina Tili; Ian C Davis
Journal:  Virology       Date:  2020-03-23       Impact factor: 3.513

Review 9.  The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.

Authors:  Shengguang Wang; Zhen Li; Xinyu Wang; Shiming Zhang; Peng Gao; Zuorong Shi
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

10.  ATP catabolism by tissue nonspecific alkaline phosphatase contributes to development of ARDS in influenza-infected mice.

Authors:  Parker S Woods; Lauren M Doolittle; Judy M Hickman-Davis; Ian C Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-05       Impact factor: 6.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.